{"id":"W2120711586","doi":"10.1016/s1470-2045(14)70005-1","title":"Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Rituximab; Follicular lymphoma; Clinical endpoint; Internal medicine; International Prognostic Index; Vincristine; Regimen; Prednisone; Cyclophosphamide; Population; Lymphoma; Oncology; Gastroenterology; Surgery; Randomized controlled trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008572512,0.0001330486,0.001459378,0.0001699138,0.0000259267,0.000003041964,0.0001050755,0.0000571342,0.00006992476],"category_scores_gemma":[0.00009768567,0.00008379804,0.0001342451,0.0004038115,0.0001309797,0.00001223294,0.00005334036,0.00005129539,0.000001523377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001163654,"about_ca_system_score_gemma":0.00006440347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003414883,"about_ca_topic_score_gemma":0.0002135619,"domain_scores_codex":[0.998565,0.0004168245,0.0004512981,0.0002020121,0.0001652204,0.0001996618],"domain_scores_gemma":[0.9985726,0.000709341,0.0002244334,0.0003774209,0.00005881977,0.00005742405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1515383,0.0568159,0.5843416,0.0003221491,0.01344802,0.002028627,0.007205698,0.0005179915,0.006185865,0.00103362,0.0002654064,0.1762968],"study_design_scores_gemma":[0.6829539,0.008291801,0.2790414,0.00003844142,0.009897011,0.000105362,0.0006754579,0.007553601,0.003137552,0.00003877254,0.008110094,0.0001566422],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966029,0.0004603176,0.0000429115,0.0006687423,0.00003804183,0.0009465871,0.00003821354,0.00001094882,0.00119137],"genre_scores_gemma":[0.9988902,0.0005382285,0.0001549907,0.000230883,0.00004691976,0.00006503441,0.00001767372,0.00000864762,0.00004740963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5314156,"threshold_uncertainty_score":0.3417185,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02571659792626668,"score_gpt":0.3512134032239786,"score_spread":0.325496805297712,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}